13F filer · CIK 1009207 ↗

D. E. Shaw

You are looking at Q4 2017. See the latest, Q2 2026 →

Reported value

$72.62B

+12% on the quarter before

Positions

3,546

541 new · 419 sold out

Top 10

9.5%

of the value

Est. gain

+$1.72B

on stocks held all quarter

Est. return

+4.3%

on those stocks since Q3 2017

Filed

Feb 14, 2018

On SEC EDGAR ↗

Positions as of Dec 31, 2017, from D. E. Shaw's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 18% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.

Apple1.3%
Nxp Semiconductors N V1.1%
Time Warner Inc1.1%
Meta1.1%
Merck & Co Inc1.1%
Alphabet0.9%
Dell Technologies Inc0.7%
Alphabet0.7%IBM0.7%
General Electric Co0.7%
Verisign Inc0.7%
Comcast Corp New0.7%
S&P Global Inc0.7%
Johnson & Johnson0.6%
Visa Inc.0.6%
Amgen Inc0.6%
Tjx Cos Inc New0.6%
Qualcomm0.6%
Priceline Grp IncPUT0.5%
T Mobile Us Inc0.5%
Marathon Pete Corp0.5%
Yum Brands Inc0.5%
Medtronic Plc0.5%
Walgreens Boots Alliance Inc0.5%

Largest buys

Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. General Electric Co~$499.4MAdded · 0.0% → 0.7%+28,621,493 shares
  2. Meta~$467.8MAdded · 0.5% → 1.1%+2,650,923 shares
  3. Time Warner Inc~$331.2MAdded · 0.8% → 1.1%+3,620,521 shares
  4. Merck & Co Inc~$312.0MAdded · 0.8% → 1.1%+5,544,095 shares
  5. Monsanto Co New~$244.6MAdded · 0.1% → 0.4%+2,094,205 shares
  6. Medtronic Plc~$226.3MAdded · 0.2% → 0.5%+2,802,318 shares
  7. Broadcom Ltd~$205.3MAdded · 0.1% → 0.4%+799,289 shares
  8. IBM~$176.5MAdded · 0.5% → 0.7%+1,150,749 shares
  9. Allergan Plc~$176.0MAdded · 0.0% → 0.3%+1,075,677 shares
  10. Regeneron Pharmaceuticals~$167.7MAdded · 0.1% → 0.3%+446,025 shares

Largest sells

Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Apple~$439.6MCut · 1.9% → 1.3%−2,597,672 shares
  2. Netflix~$300.0MCut · 0.7% → 0.3%−1,562,805 shares
  3. Verizon Communications Inc~$253.0MCut · 0.5% → 0.1%−4,779,603 shares
  4. Tesla~$240.7MSold out · 0.4% → 0.0%−705,618 shares
  5. Alibaba~$236.1MCut · 0.4% → 0.0%−1,369,266 shares
  6. T Mobile Us Inc~$230.0MSold out · 0.4% → 0.0%−2,302,741 shares
  7. Hershey Co~$209.6MCut · 0.3% → 0.0%−1,846,669 shares
  8. Wells Fargo Co New~$181.0MCut · 0.5% → 0.2%−2,982,832 shares
  9. Tjx Cos Inc New~$177.5MCut · 0.9% → 0.6%−2,320,890 shares
  10. Mondelez Intl Inc~$154.5MCut · 0.5% → 0.2%−3,610,108 shares

Holdings

As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
AppleCOM · shares −32% · price +9.8%1.3%$917.5M+$81.9M
Nxp Semiconductors N VCOM · shares +22% · price +3.5%1.1%$828.7M+$23.3M
Time Warner IncCOM NEW · shares +69% · price −10.7%1.1%$813.3M−$57.9M
MetaCL A · shares +139% · price +3.3%1.1%$803.2M+$10.6M
Merck & Co IncCOM · shares +67% · price −12.1%1.1%$774.7M−$63.8M
AlphabetCAP STK CL A · shares +15% · price +8.2%0.92%$669.9M+$44.0M
Dell Technologies IncCOM CL V · shares −4.6% · price +5.3%0.75%$544.5M+$27.3M
AlphabetCAP STK CL C · shares +29% · price +9.1%0.75%$543.3M+$35.3M
IBMCOM · shares +50% · price +5.7%0.73%$530.5M+$19.2M
General Electric CoCOM · shares +5,671% · price −27.8%0.70%$508.3M−$3.4M
Verisign IncCOM · shares +5.8% · price +7.6%0.69%$504.4M+$33.5M
Comcast Corp NewCL A · shares −21% · price +4.1%0.67%$483.0M+$18.9M
S&P Global IncCOM · shares −9.3% · price +8.4%0.66%$481.7M+$37.2M
Johnson & JohnsonCOM · shares −16% · price +7.5%0.62%$449.9M+$31.3M
Visa Inc.COM CL A · shares −18% · price +8.3%0.60%$437.5M+$33.7M
Amgen IncCOM · shares +50% · price −6.7%0.59%$428.8M−$20.6M
Tjx Cos Inc NewCOM · shares −30% · price +3.7%0.58%$418.5M+$14.9M
QualcommCOM · shares −12% · price +23.5%0.56%$407.2M+$77.5M
Priceline Grp IncPUTCOM NEW · shares −20%0.55%$396.7M—
T Mobile Us IncCOM · shares +0.3% · price +3.0%0.53%$388.3M+$11.3M
Marathon Pete CorpCOM · shares −15% · price +17.7%0.51%$371.0M+$55.7M
Yum Brands IncCOM · shares +25% · price +10.9%0.49%$356.2M+$27.9M
Medtronic PlcSHS · shares +184% · price +3.8%0.48%$349.5M+$4.5M
Walgreens Boots Alliance IncCOM · shares +60% · price −6.0%0.46%$334.3M−$13.2M
NvidiaPUTCOM · shares −13%0.45%$329.6M—
Total · 3,546 positions100%$72.62B+$1.72B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2017 to Q4 2017: 2,141 stocks held throughout, up $1.72B (+4.3%).

  1. Apple+$81.9M+10%
  2. Qualcomm+$77.5M+23%
  3. Wal-Mart Stores Inc+$56.0M+26%
  4. Marathon Pete Corp+$55.7M+18%
  5. Dollar Tree Inc+$45.0M+24%
  6. Celgene Corp−$31.4M−28%
  7. Realogy Hldgs Corp−$38.4M−20%
  8. Pg&E Corp−$44.6M−34%
  9. Time Warner Inc−$57.9M−11%
  10. Merck & Co Inc−$63.8M−12%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$300.00B$150.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$210.20B+26%SEC ↗
Q1 2026$166.31B−9%SEC ↗
Q4 2025$182.42B+3%SEC ↗
Q3 2025$177.16B+26%SEC ↗
Q2 2025$141.06B+26%SEC ↗
Q1 2025$112.35B−18%SEC ↗
Q4 2024$136.27B+17%SEC ↗
Q3 2024$116.49B+9%SEC ↗
Q2 2024$106.92B−8%SEC ↗
Q1 2024$116.85B+2%SEC ↗
Q4 2023$114.44B+19%SEC ↗
Q3 2023$95.78B−2%SEC ↗
Q2 2023$97.90B+5%SEC ↗
Q1 2023$93.41B+3%SEC ↗
Q4 2022$90.48B+8%SEC ↗
Q3 2022$83.73B−2%SEC ↗
Q2 2022$85.30B−20%SEC ↗
Q1 2022$106.83B−11%SEC ↗
Q4 2021$120.60B+9%SEC ↗
Q3 2021$110.81B−4%SEC ↗
Q2 2021$115.86B+12%SEC ↗
Q1 2021$103.59B−7%SEC ↗
Q4 2020$111.85B+14%SEC ↗
Q3 2020$97.71B+16%SEC ↗
Q2 2020$83.95B+31%SEC ↗
Q1 2020$64.09B−27%SEC ↗
Q4 2019$87.45B+8%SEC ↗
Q3 2019$81.21B+1%SEC ↗
Q2 2019$80.19B+4%SEC ↗
Q1 2019$77.39B+7%SEC ↗
Q4 2018$72.58B−13%SEC ↗
Q3 2018$83.24B+9%SEC ↗
Q2 2018$76.66B+4%SEC ↗
Q1 2018$73.46B+1%SEC ↗
Q4 2017$72.62B+12%SEC ↗
Q3 2017$65.09B+8%SEC ↗
Q2 2017$60.46B+6%SEC ↗
Q1 2017$56.89B−3%SEC ↗
Q4 2016$58.87B+4%SEC ↗
Q3 2016$56.68B+5%SEC ↗
Q2 2016$54.23B−3%SEC ↗
Q1 2016$55.73BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.